These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7019795)

  • 1. Intraamniotic infection due to group G streptococcus: treatment and antibody response.
    Larsen JW; London WT; Baker CJ; Curfman BL; Sever JL
    Obstet Gynecol; 1981 Aug; 58(2):222-6. PubMed ID: 7019795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Penicillin treatment for group B streptococcal meningitis in the rhesus monkey.
    Larsen JW; London WT; Palmer AE; Curfman BL; Bronsteen RA
    Obstet Gynecol; 1981 Mar; 57(3):330-4. PubMed ID: 7007941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of antibody to native type III polysaccharide of group B Streptococcus in infant infection.
    Baker CJ; Edwards MS; Kasper DL
    Pediatrics; 1981 Oct; 68(4):544-9. PubMed ID: 7033911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prevention and treatment of neonatal group B streptococcal infections.
    Givner LB; Baker CJ
    Adv Pediatr Infect Dis; 1988; 3():65-90. PubMed ID: 3061395
    [No Abstract]   [Full Text] [Related]  

  • 5. Quantitative determination of antibody to capsular polysaccharide in infection with type III strains of group B Streptococcus.
    Baker CJ; Kasper DL; Tager IRAB ; Paredes A; Alpert S; McCormack WM; Goroff D
    J Clin Invest; 1977 May; 59(5):810-8. PubMed ID: 856869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection.
    Baker CJ; Kasper DL
    N Engl J Med; 1976 Apr; 294(14):753-6. PubMed ID: 768760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of a group B streptococcal prophylaxis protocol combining high-risk treatment and low-risk screening.
    Reisner DP; Haas MJ; Zingheim RW; Williams MA; Luthy DA
    Am J Obstet Gynecol; 2000 Jun; 182(6):1335-43. PubMed ID: 10871447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reducing neonatal group B streptococcal disease.
    Wendel GD; McIntire DJ; Leveno KJ
    N Engl J Med; 2000 May; 342(18):1367-8. PubMed ID: 10798941
    [No Abstract]   [Full Text] [Related]  

  • 9. Persistence of penicillin G benzathine in pregnant group B streptococcus carriers.
    Weeks JW; Myers SR; Lasher L; Goldsmith J; Watkins C; Gall SA
    Obstet Gynecol; 1997 Aug; 90(2):240-3. PubMed ID: 9241301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of intramuscular penicillin in the eradication of group B streptococcal colonization at delivery.
    Pinette MG; Thayer K; Wax JR; Blackstone J; Cartin A
    J Matern Fetal Neonatal Med; 2005 May; 17(5):333-5. PubMed ID: 16147846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal dosing of penicillin G in the third trimester of pregnancy for prophylaxis against group B Streptococcus.
    Johnson JR; Colombo DF; Gardner D; Cho E; Fan-Havard P; Shellhaas CS
    Am J Obstet Gynecol; 2001 Oct; 185(4):850-3. PubMed ID: 11641664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody to type III group B Streptococcus in the rhesus monkey.
    Larsen JW; Harper JS; London WT; Baker CJ; Curfman BL; Kasper DL; Sever JL
    Am J Obstet Gynecol; 1983 Aug; 146(8):958-62. PubMed ID: 6349364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late third-trimester treatment of rectovaginal group B streptococci with benzathine penicillin G.
    Bland ML; Vermillion ST; Soper DE
    Am J Obstet Gynecol; 2000 Aug; 183(2):372-6. PubMed ID: 10942472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistence of penicillin G benzathine in pregnant group B streptococcus carriers.
    Rosenberg K
    J Nurse Midwifery; 1998; 43(2):125-6. PubMed ID: 9581103
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy of human immunoglobulin and penicillin G in treatment of experimental group B streptococcal infection.
    Kim KS
    Pediatr Res; 1987 Mar; 21(3):289-92. PubMed ID: 3550675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No increase in rates of early-onset neonatal sepsis by antibiotic-resistant group B Streptococcus in the era of intrapartum antibiotic prophylaxis.
    Chen KT; Puopolo KM; Eichenwald EC; Onderdonk AB; Lieberman E
    Am J Obstet Gynecol; 2005 Apr; 192(4):1167-71. PubMed ID: 15846197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Group G streptococci in newborns.
    Florman AL
    Med Times; 1981 Jul; 109(7):27-30. PubMed ID: 7022092
    [No Abstract]   [Full Text] [Related]  

  • 18. The clinical significance of group B streptococci.
    Christensen KK; Christensen P; Hägerstrand I; Lindén V; Nordbring F; Svenningsen N
    J Perinat Med; 1982; 10(3):133-46. PubMed ID: 7050338
    [No Abstract]   [Full Text] [Related]  

  • 19. Level of maternal IgG anti-group B streptococcus type III antibody correlated with protection of neonates against early-onset disease caused by this pathogen.
    Lin FY; Weisman LE; Azimi PH; Philips JB; Clark P; Regan J; Rhoads GG; Frasch CE; Gray BM; Troendle J; Brenner RA; Moyer P; Clemens JD
    J Infect Dis; 2004 Sep; 190(5):928-34. PubMed ID: 15295698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pediatric grand round. Group B hemolytic streptococcal infection in the newborn.
    Peterson RD
    J Med Assoc State Ala; 1976 Feb; 45(8):32-6. PubMed ID: 801362
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.